Oramed Pharmaceuticals Inc. (ORMP) stock
ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$4.03−0.10 (-2.42%)
Close on Nov 12, 2026Market cap $167.64MP/E 1.2Yield 6.20%
Oramed Pharmaceuticals statistics
76 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- Jan 16, 2026
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
Share statisticsIndustry
- Shares Change (YoY)
- 0.53%
- 10.9%
- Shares Change (QoQ)
- 4.66%
- 0.51%
- Float
- 32M
- 49M
- Shares Held by Insiders
- 23.9%
- 12.1%
- Shares Held by Institutions
- 40.3%
- 56.4%
Short sellingIndustry
- Short Interest
- 1M
- –
- Short Interest Change
- -7.42%
- -0.76%
- Short % of Float
- 4.25%
- 9.04%
- Short % of Shares Outstanding
- 3.23%
- 6.30%
- Days to Cover
- 11.34
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $5.47
- –
- 52-Week Low
- $2.25
- –
- 20-Day Moving Average
- $4.07
- –
- 50-Day Moving Average
- $4.38
- –
- 200-Day Moving Average
- $4.05
- –
- Average True Range (14)
- $0.17
- –
- Price Change (1 Week)
- 3.60%
- 1.51%
- Price Change (1 Month)
- -2.66%
- -2.35%
- Price Change (3 Months)
- -10.0%
- -21.1%
- Price Change (6 Months)
- -14.8%
- -22.6%
- Price Change (YTD)
- 41.4%
- -22.6%
- Price Change (1 Year)
- 66.5%
- -20.7%
- Price Change (3 Years)
- 102.5%
- -27.4%
- Price Change (5 Years)
- -85.9%
- -77.3%
- Price Change (10 Years)
- -35.7%
- -62.7%
- Average Volume (10 Days)
- 113,906
- –
- Average Volume (20 Days)
- 118,604
- –
- Average Volume (90 Days)
- 172,671
- –
- Relative Volume
- 0.65
- 0.79
- Relative Strength Index (14)
- 44.5
- 44.7
- Volatility (1 Year)
- 53.0%
- 80.4%
- Beta (5 Years)
- 1.43
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- 71.3%
- -51.2%
- Return on Assets (ROA)
- 46.6%
- -40.6%
- Return on Invested Capital (ROIC)
- -8.49%
- -32.9%
- Return on Capital Employed (ROCE)
- -4.14%
- -38.0%
Financial positionIndustry
- Current Ratio
- 6.07
- 3.30
- Quick Ratio
- 3.12
- 2.42
GrowthIndustry
- Net Income Growth (YoY)
- 230.4%
- -14.4%
- EPS Growth (YoY)
- 241.0%
- -11.7%
- Revenue Growth (3Y CAGR)
- -9.55%
- 2.25%
- Revenue Growth (5Y CAGR)
- -5.85%
- 6.41%
- EPS Growth (3Y CAGR)
- 24.4%
- -0.17%
- EPS Growth (5Y CAGR)
- 12.8%
- 3.77%
EfficiencyIndustry
- Profits Per Employee
- $11.15M
- -$683.67K
- Employee Count
- 13
- 75
- WACC
- 12.1%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- $189.10M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $29.52M
- $17.46M
- Net Cash Per Share
- $0.71
- $0.72
- Working Capital
- $47.93M
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- -$13.00K
- -$944.00K
- FCF Per Share
- -$0.08
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 86.4%
- -20.8%
- FCF Yield
- -1.89%
- -9.58%
- Dividend Yield
- 6.20%
- 1.88%
- Shareholder Yield
- 6.20%
- 0.00%
- Dividend Per Share
- $0.25
- $0.83
- Years of Dividend Growth
- 0
- 0
Taxes and interestIndustry
- Income Tax
- $44.22M
- $74.00K
- Effective Tax Rate
- 23.4%
- 20.9%
Scores and fair valueIndustry
- Altman Z-Score
- 1.68
- 0.30
- Piotroski F-Score
- 3
- 4
- Lynch Fair Value
- $43.78
- –
- Lynch Upside
- 986.3%
- -28.1%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ORMP | S&P 500 | Difference | ORMP per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -5.6% | -2.7% | −2.9 pts | ||
| 3 months | -5.6% | -1.7% | −3.9 pts | ||
| Year to date | +51.7% | +11.9% | +39.8 pts | ||
| 1 year | +75.0% | +12.0% | +63.0 pts | ||
| 3 years | +125.2% | +78.2% | +47.0 pts | +31.1% | +21.2% |
| 5 years | -84.9% | +73.2% | −158.2 pts | -31.5% | +11.6% |
| 10 years | -31.1% | +309.6% | −340.7 pts | -3.7% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M ORMP shares were sold short on Oct 30, 2026, down 7.4% from the previous report, or 4.25% of the shares available to trade. At recent volumes it would take 11.3 days to buy them back. Over the last 20 sessions, 50.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,343,457 | -7.4% | 118,509 | 11.3 |
| Oct 15, 2026 | 1,451,095 | +1.2% | 139,567 | 10.4 |
| Sep 30, 2026 | 1,433,436 | +9.6% | 195,596 | 7.3 |
| Sep 15, 2026 | 1,307,745 | +13.3% | 175,933 | 7.4 |
| Aug 31, 2026 | 1,154,241 | +12.5% | 269,352 | 4.3 |
| Aug 14, 2026 | 1,025,767 | +22.8% | 175,277 | 5.8 |
| Jul 31, 2026 | 835,493 | +9.2% | 146,714 | 5.7 |
| Jul 15, 2026 | 765,356 | -12.8% | 306,923 | 2.5 |
| Jun 30, 2026 | 877,849 | +53.9% | 738,846 | 1.2 |
| Jun 15, 2026 | 570,447 | -13.5% | 187,604 | 3.0 |
| May 29, 2026 | 659,464 | +3.8% | 213,820 | 3.1 |
| May 15, 2026 | 635,431 | -2.3% | 186,020 | 3.4 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?